Today's Trend
SS&C Technologies (NASDAQ: SSNC) — Shares moved lower after the company reported Q1 results and a flurry of analyst and insider activity. Below are the investor-relevant highlights that likely explain the price decline despite broadly solid quarter metrics.
- Q1 results beat consensus: adjusted EPS $1.69 and revenue ~$1.65B, with revenue +8.8% YoY and management raising full-year 2026 EPS and revenue ranges — a fundamental positive for growth and profitability. SS&C Technologies Releases Q1 2026 Financial Results
- UBS raised its price target to $115 and kept a Buy rating, signaling conviction from a large shop and implying meaningful upside versus current levels. Benzinga
- Q2 guidance: EPS guided to $1.640–1.700 (slightly above consensus EPS) but revenue guided to ~$1.6–1.7B (broadly in line or modestly below some estimates). Guidance is not conservative, but it lacked a big step-up that some investors hoped to see after the beat. SS&C Q1 Results - Press Release / Slide Deck
- Full earnings call and transcripts are available — useful for color on client wins, backlog, margins and M&A commentary that will matter for upcoming quarters. SS&C Q1 2026 Earnings Call Transcript (InsiderMonkey)
- Several analysts trimmed price targets or moved to a more cautious stance (Morgan Stanley cut target to $78 and set Equal Weight; Needham trimmed to $90 though kept Buy; Jefferies reduced its target to $92) — analyst mark-downs and talk of sector multiple compression can pressure the stock even when results are solid. Benzinga (analyst moves)
- Market commentary suggests a post-earnings “sell-the-news” reaction; Quiver notes an analyst price-target cut cited sector multiple compression as a headwind. SS&C Technologies falls 4% as investors digest Q1 results and a price-target cut
- Insider selling: a disclosed sale of 150,000 shares by Normand A. Boulanger was reported, which can weigh on near-term sentiment even if not indicative of company fundamentals. Quiver Quantitative (insider activity)
What to watch next: management’s execution against Q2 guidance, organic growth cadence, margin progress, and whether analyst sentiment stabilizes (or more PT cuts follow). Those items will drive direction from here.